Matthias Von Herrath

Matthias Von Herrath

Company: Novo Nordisk

Job title: Vice President & Senior Medical Officer, Global Chief Medical Office

Seminars:

Can Antigen Specific Immune Therapy Control Tissue Resident Effector T cells in Human Type 1 Diabetes? 11:30 am

Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.